July 14, 2025

Premenstrual Disorders Linked With Increased Risk of Cardiovascular Diseases 

A large Swedish study found that women diagnosed with premenstrual disorders had a modest but consistent increase in the risk of several types of cardiovascular diseases, including stroke, hypertension, and arrhythmia.

Conexiant

July 11, 2025

Small Air Pollution Increases Linked to Fibrosis

A large imaging study found that even small increases in long-term exposure to fine particulate air pollution were linked to higher levels of myocardial fibrosis, a known marker of adverse heart remodeling, in both healthy individuals and patients with dilated cardiomyopathy.

Conexiant

July 10, 2025

HHS Scraps Preventive Care Panel Meeting

HHS unexpectedly canceled a meeting of the U.S. Preventive Services Task Force, prompting fears it may be dismantled following similar moves by Secretary Robert F. Kennedy Jr. at other federal health agencies.

Conexiant

July 10, 2025

No Heart Risk Found With Triptan Use

A large real-world study found no significant increase in short-term heart attack or stroke risk among migraine patients using triptans, including those with cardiovascular risk factors.

Conexiant

July 09, 2025

Medical Oddities: Mondays May Mess With Hormones

Monday cortisol, THC slip-ups, rewiring retinas, tea-buffed muscles, and psyche gyms are what’s the buzz this week!

Conexiant

July 09, 2025

PXF: A Silent Threat to Vision

A study in the clinical recognition and management of pseudoexfoliation syndrome

The Ophthalmologist

July 09, 2025

Once-Weekly Combo Injection Cuts Weight by 20% 

A large 68-week clinical trial found that a once-weekly combination injection of cagrilintide and semaglutide led to significant and sustained weight loss in adults with overweight or obesity, with over half achieving at least 20% weight reduction.

Conexiant

July 09, 2025

ESC: Vaccines May Prevent Major Heart Events

A new ESC clinical statement finds that common vaccines, including those for influenza and COVID-19, may lower cardiovascular risks such as heart attack, stroke, and heart failure, particularly in high-risk patients.

Conexiant

July 09, 2025

Evening Dosing Lowers BP Better, Study Finds

Researchers found that bedtime dosing of olmesartan-amlodipine improved nocturnal blood pressure control without increasing adverse events in patients with hypertension.

Conexiant